Alkhidir, Abdulazeem Abdulsalam Ibrahim
Holland, Martin J.
Elhag, Wafa Ibrahim
Williams, Charlotte A.
Breuer, Judith
Elemam, Abdah Elfatih
El Hussain, Khalid Mohamed Khalid
Ournasseir, Mohammed Elfatih Hussein
Pickering, Harry
Funding for this research was provided by:
EU Horizon2020 (733373)
Article History
Received: 23 April 2019
Accepted: 25 October 2019
First Online: 4 November 2019
Ethics approval and consent to participate
: The study and its procedures were approved by the Sudan Government/Federal Ministry of Health/National Health Research Ethics Committee and Al-Neelain University research ethics committee. Verbal consent was obtained from community leaders, children or participants’ guardians on their behalf. During the survey, all children with trachomatous inflammation-follicular (TF) and/or trachomatous inflammation-intense (TI) were treated with a single height-based dose of oral azithromycin in accordance with WHO and national protocols.
: Not applicable.
: The authors declare that they have no competing interests.